Logo image of AMZE

AMAZE HOLDINGS INC (AMZE) Stock Fundamental Analysis

NYSEARCA:AMZE - NYSE Arca - US35804X1019 - Common Stock - Currency: USD

0.4899  0 (-0.79%)

After market: 0.4899 0 (0%)

Fundamental Rating

1

Taking everything into account, AMZE scores 1 out of 10 in our fundamental rating. AMZE was compared to 32 industry peers in the Beverages industry. While AMZE seems to be doing ok healthwise, there are quite some concerns on its profitability. AMZE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

AMZE had negative earnings in the past year.
AMZE had a negative operating cash flow in the past year.
In the past 5 years AMZE always reported negative net income.
AMZE had a negative operating cash flow in each of the past 5 years.
AMZE Yearly Net Income VS EBIT VS OCF VS FCFAMZE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M

1.2 Ratios

AMZE has a Return On Assets of -60.78%. This is amonst the worse of the industry: AMZE underperforms 93.75% of its industry peers.
The Return On Equity of AMZE (-181.35%) is worse than 81.25% of its industry peers.
Industry RankSector Rank
ROA -60.78%
ROE -181.35%
ROIC N/A
ROA(3y)-334.97%
ROA(5y)-289.36%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AMZE Yearly ROA, ROE, ROICAMZE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for AMZE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AMZE Yearly Profit, Operating, Gross MarginsAMZE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

5

2. Health

2.1 Basic Checks

AMZE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AMZE has been increased compared to 1 year ago.
AMZE has more shares outstanding than it did 5 years ago.
AMZE has a worse debt/assets ratio than last year.
AMZE Yearly Shares OutstandingAMZE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M
AMZE Yearly Total Debt VS Total AssetsAMZE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

AMZE has an Altman-Z score of -9.45. This is a bad value and indicates that AMZE is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -9.45, AMZE is doing worse than 78.13% of the companies in the same industry.
There is no outstanding debt for AMZE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -9.45
ROIC/WACCN/A
WACC8.83%
AMZE Yearly LT Debt VS Equity VS FCFAMZE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 10M -10M

2.3 Liquidity

A Current Ratio of 1.50 indicates that AMZE should not have too much problems paying its short term obligations.
The Current ratio of AMZE (1.50) is comparable to the rest of the industry.
AMZE has a Quick Ratio of 1.43. This is a normal value and indicates that AMZE is financially healthy and should not expect problems in meeting its short term obligations.
AMZE's Quick ratio of 1.43 is fine compared to the rest of the industry. AMZE outperforms 68.75% of its industry peers.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.43
AMZE Yearly Current Assets VS Current LiabilitesAMZE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M

0

3. Growth

3.1 Past

AMZE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 75.38%, which is quite impressive.
Looking at the last year, AMZE shows a very negative growth in Revenue. The Revenue has decreased by -83.62% in the last year.
The Revenue for AMZE have been decreasing by -43.97% on average. This is quite bad
EPS 1Y (TTM)75.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.18%
Revenue 1Y (TTM)-83.62%
Revenue growth 3Y-43.97%
Revenue growth 5YN/A
Sales Q2Q%-74.61%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AMZE Yearly Revenue VS EstimatesAMZE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

0

4. Valuation

4.1 Price/Earnings Ratio

AMZE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AMZE Price Earnings VS Forward Price EarningsAMZE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AMZE Per share dataAMZE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 -0.1 -0.15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

AMZE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AMAZE HOLDINGS INC

NYSEARCA:AMZE (5/1/2025, 8:45:04 PM)

After market: 0.4899 0 (0%)

0.4899

0 (-0.79%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners2.77%
Inst Owner ChangeN/A
Ins Owners31.99%
Ins Owner ChangeN/A
Market Cap8.19M
AnalystsN/A
Price TargetN/A
Short Float %3.28%
Short Ratio2.49
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 27.37
P/FCF N/A
P/OCF N/A
P/B 5.54
P/tB 5.54
EV/EBITDA N/A
EPS(TTM)-0.17
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)-0.12
OCFYN/A
SpS0.02
BVpS0.09
TBVpS0.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -60.78%
ROE -181.35%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-334.97%
ROA(5y)-289.36%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.5
Quick Ratio 1.43
Altman-Z -9.45
F-Score5
WACC8.83%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)75.38%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.18%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-83.62%
Revenue growth 3Y-43.97%
Revenue growth 5YN/A
Sales Q2Q%-74.61%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y70.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y59.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y59.83%
OCF growth 3YN/A
OCF growth 5YN/A